3Feng D, Lindpaintner K, Larson MG, et al. Platelet glycoprotein III a P1 (a) polymorphism, fibrinogen, and platelet aggregability : the Framingham Heart Study. Circulation, 2001, 104: 140-144.
4Liu AH, Lin YH, Yang M, et al. Development of the fingerprints for the quality of the roots of Salvia miltiorrhiza and its related preparations by HPLC-DAD and LC-MS (n) . J Chromatogr B Analyt Teehnol Biomed Life Sci, 2007, 846:32-41.
3Testa A, Galeri S, Villafane JH, et al. Efficacy of short- term intrapulmonary percussive ventilation in patients with chronic obstructive pulmonary disease[J]. Disabil Rehabil,2014,8(7) : 1-5.
4Theander K, Hasselgren M, Luhr K, et al. Symptoms and impact of symptoms on function and health in patients with chronic obstructive pulmonary disease and chronic heart failure in primary health care[J]. Int J Chron Ob- struct Pulmon Dis, 2014,18(9) : 785-794.
5Kim SW,Lee JH,Sim YS,et al. Prevalence and risk fac- tors for reflux esophagitis in patients with chronic ob- structive pulmonary disease[J]. Korean J Intern Med, 2014,29 (4) : 466-473.
6Park YM,Chung WJ ,Lee SP,et al. Efficacy of inhaled il- oprost in cor pulmonale and severe pulmonary hyperten- sion associated with tuberculous destroyed lung[J]. J Car- diovasc Ultrasound, 2014,22 ( 2 ) : 95-97.
7Donnelly LE. The lipidome: a new player in chronic ob- structive pulmonary disease pathophysiology[J]. Am J Respir Crit Care Med,2014,190(2) :124-125.
8Kosanovic D, Dahal BK, Peters DM, et al. Histological char- acterization of mast cell chymase in patients with pulmonary hypertension and chronic obstructive pulmonary disease[J]. Pulm Circ,2014,4(1) : 128-136.
